ADS Basic Orals Session 1
Tracks
Breakout 2: Meeting Room 6
Thursday, August 22, 2024 |
4:00 PM - 6:00 PM |
Meeting Room 6 |
Speaker
Mr Richard He
Student
The University of Sydney
Regulation of Anti-Inflammatory CD163+ Macrophages in Sex Specific Models of Non-Alcoholic Steatohepatitis in Type 2 Diabetes
4:00 PM - 4:15 PMBiography
Richard He is a research student at the University of Sydney working with the Greg Brown Diabetes and Endocrinology Research Laboratory. His current research emphasises the role of the immune system, particularly macrophages, in the pathogenesis of the complications of type 2 diabetes mellitus.
Dr Abdul Waheed Khan
Research Fellow
Monash University
Drug Repurposing of an AP-1 inhibitor T-5224 for Diabetes Associated Atherosclerosis.
4:15 PM - 4:30 PMBiography
Dr. Abdul Waheed Khan is a previous Heart Foundation postdoctoral fellow and a recipient of General Grants (Diabetes Australia), Diabetes Wellness Sverige (Sweden) and ECR award (Karolinska, Sweden). He is an early-mid career Research Fellow leading a cardiovascular research group within the Department of Diabetes, Monash University.
Dr Nicholas Hunt
Senior Lecturer
University of Sydney
Nanoformulations of Low dose Oral-liraglutide to Improve Metabolic Health in aging mice.
4:30 PM - 4:45 PMBiography
Nick is a Senior Lecturer in the School of Medical Sciences and CEO of the biotech firm Endo Axiom that is taking oral nanoformulation of insulin to clinical trials next year.
Dr Vance Matthews
Head Of Translational Sciences (Dobney Hypertension Centre)
University of Western Australia
SGLT1/2 Inhibition improves Glycemic control and Multi-organ Protection in Type 1 Diabetes.
4:45 PM - 5:00 PMBiography
Dr Vance Matthews is the Head of 'The Dobney Hypertension Centre' Translational Sciences Laboratory at the University of Western Australia. He has published >100 peer-reviewed papers during his career (24 of which were as first author and 29 of which were as last author).
Dr Danqing Min
Principal Hospital Scientist
Royal Prince Alfred Hospital
A Low Volume Exercise Intervention Alters the Type-2 Diabetic Lipidome, Reducing Circulating Toxic Deoxyceramides
5:00 PM - 5:15 PMBiography
Dr Min is a Principal Hospital Scientist at Royal Prince Alfred Hospital and the Scientific Head at the Greg Brown Diabetes & Endocrine Research Laboratory, The University of Sydney.
Her principal research interest is translational research to understand the molecular mechanisms of inflammation responses during the development of diabetes complications.
Miss Charlotte Rowley
Phd Candidate
Murdoch University / Diabetes WA
Exploring Biological Diversity in Dietary Responses for Type 2 Diabetes Prevention
5:15 PM - 5:30 PMBiography
Charlotte is a PhD candidate at Murdoch University, focusing on precision nutrition and metabolic health. Charlotte's work explores the biological diversity in dietary responses to improve health outcomes. Charlotte is qualified as an Accredited Practicing Dietitian and Credentialled Diabetes Educator.
Miss Ellen Tejo
PhD Student
Mater Research Institute / Translational Research Institute
Understanding Diabetic Kidney Disease, COVID-19 infection, and Mitochondrial Dysfunction
5:30 PM - 5:45 PMBiography
Ellen is a third year PhD candidate in Mater Research Institute - Translational Research Institute, The University of Queensland (MRI-TRI, UQ) investigating Diabetic Kidney Disease.
Miss Michelia Yu
Research Assistant
Kolling Institute
The effect of Weight loss, before or during Pregnancy, in mothers with obesity, on structural and metabolic changes of offspring adipose tissue.
5:45 PM - 6:00 PMBiography
Michelia is a research assistant with the Pregnancy, Diabetes and Obesity group at the Kolling Institute. She will be presenting her honours work.
A/Prof Melinda Coughlan
Head: Glycation, Nutrition and Metabolism Laboratory
School of Translational Medicine, Monash University
Chairperson
Biography
Associate Professor Melinda Coughlan is Head of the Glycation, Nutrition & Metabolism laboratory within the Department of Diabetes, School of Translational Medicine, Monash University. She studied Biology and Nutrition before obtaining a PhD from The University of Melbourne. Dr Coughlan completed postdoctoral training at the Baker Heart and Diabetes Institute, before moving her lab to Monash University in 2016. Her research focuses on gaining an understanding of the molecular mechanisms driving the development of diabetic kidney disease and discovering novel therapeutic targets. Associate Professor Coughlan has authored >90 peer-reviewed manuscripts and contributes to the discipline through her role as Council Member of the Australian and New Zealand Society of Nephrology and Editorial Board member of the journal Diabetes.
Dr Tomasz Block
PhD Candidate
Monash University
Chairperson
Biography
Dr Tomasz Block is an Endocrinology Research Fellow at Alfred Hospital in Melbourne. Alongside clinical practice, he is undertaking a NHMRC funded PhD supervised by Professors Merlin Thomas and Mark Cooper within the Department of Diabetes at Monash University, investigating the role of RNA therapy to treat diabetic cardiovascular and renal complications.